OVC 2023: What we’ve learned and what questions remain after the 7-year MiSight® 1 day clinical trial (Recorded Webcast - Sponsored)
Learning Objectives
- Develop an understanding of how different measures can be used to fully understand treatment efficacy in myopia management
- Develop an understanding of how MiSight 1 day slowed the myopia of children progressing at different rates
Max CPD hours awarded: 1.5
Session Information
Name |
---|
OVC 2023: What we’ve learned and what questions remain after the 7-year MiSight® 1 day clinical trial |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
1 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |